MANGALAM

Mangalam Drugs And Organics Limited

Source: NSE · Updated 5 Nov, 07:30 pm IST

Filed 5 Nov, 07:14 pm IST Q2 FY27 (Sep ’26)Consolidated₹ lakhs

Revenue

7,939.24

▲ 60.2% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

-115.27

vs Q2 FY26: n/a

Net profit

-720.81

vs Q2 FY26: n/a

EPS (₹)

-4.55

vs Q2 FY26: n/a

Operating margin

-1.5%

+420 bps vs Q2 FY26

Net margin

-9.1%

+570 bps vs Q2 FY26

Loss narrowed vs Q2 FY26

Revenue+60% vs Q2 FY26 · +39% vs Q1 FY27

ProfitLoss narrowed vs Q2 FY26 · Loss narrowed vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	7,939.24	5,711.93	▲ 39.0%	4,954.41	▲ 60.2%
Other income	16.82	11.17	▲ 50.6%	2.78	▲ 505.0%
Operating profit (EBITDA)*	-115.27	90.26	—	-283.77	—
Profit before tax	-899.09	-674.61	—	-1,246.67	—
Tax expense	-178.28	89.27	—	-512.04	—
Net profit	-720.81	-763.88	—	-734.63	—
EPS (₹)	-4.55	-4.83	—	-4.64	—
Operating margin	-1.5%	1.6%	−310 bps	-5.7%	+420 bps
Net margin	-9.1%	-13.4%	+430 bps	-14.8%	+570 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ lakhs except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Mangalam Drugs And Organics results, dividends & filings ›

Other results filed 5 Nov

SANSTAR Sanstar Limited›KALYANIFRG Kalyani Forge Limited›INDOWIND Indowind Energy Limited›FINKURVE Finkurve Financial Services Limited›BYKE The Byke Hospitality Ltd›SPENCERS Spencer's Retail Limited›VEEDOL Veedol Corporation Limited›ADFFOODS ADF Foods Limited›IKIO IKIO Technologies Limited›PARASHLTH Paras Healthcare Limited›BCPL BCPL Railway Infrastructure Limited›DUCON Ducon Infratechnologies Limited›

Today's results ›

MANGALAM DRUGS AND ORGANICS Q2 FY27 ; NET LOSS OF ₹7.21 CR VS LOSS ₹7.35 CR (YOY), LOSS ₹7.64 CR (QOQ)

REVENUE UP 60% AT ₹79 CR (YOY), UP 39% (QOQ)

EBITDA LOSS OF ₹1.15 CR VS LOSS ₹2.84 CR (YOY), EBITDA ₹0.90 CR (QOQ)

MARGINS AT -1.5% VS -5.7% (YOY), 1.6% (QOQ)

https://resultkal.com/r/mangalam-2026-11-05
Source: NSE filing · not investment advice

FAQ

When did Mangalam Drugs And Organics announce Q2 FY27 results?

Mangalam Drugs And Organics filed its results on NSE on 5 Nov, 07:14 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Mangalam Drugs And Organics figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← MANGALAM overview